Anna Raciborska

This trial is testing whether mifamurtide, a drug that stimulates the immune system to attack cancer cells, can improve outcomes for people with high-risk osteosarcoma, a type of bone cancer. Participants will be randomly assigned to receive either mifamurtide or the standard tre…

This phase 2 trial is testing whether adding the antibody drug naxitamab to standard chemotherapy can help children and young adults with Ewing's sarcoma that has not responded to prior treatment. Participants must have a tumor that shows a specific marker called GD2. The study w…

This study tests the drug trametinib in children with histiocytosis, a rare blood disorder, that hasn't responded to standard treatments or has a specific genetic profile. The trial aims to find the best dose and timing to improve how long children live without their disease gett…

This study tests the drug vemurafenib in children with a rare blood disorder called histiocytosis that has a specific gene mutation (BRAF) and hasn't improved with standard treatments. The goal is to find the best dose and how long to give the drug to stop the disease from gettin…

This study aims to improve how doctors diagnose and monitor histiocytosis, a rare disease that causes abnormal cell growth, in children under 18. Researchers will use a special imaging agent called fluorodeoxyglucose (18F-FDG) in PET-CT scans, along with genetic testing of tumor …